A tale of two trials: how adherence is everything in PrEP
FDA updates guidance for use of HIV and hepatitis C protease inhibitors with statins
World Health Organization issues new policy to step up TB/HIV efforts
HIV and TB in Practice for nurses
Will treatment as prevention make a difference to the UK epidemic? Health promoters respond
PrEP needs more study before being provided, UK physicians conclude
Hepatitis C subtype-1b and carriage of IL28B gene associated with improved treatment responses in HIV-co-infected patients
HIV treatment isn't a risk factor for liver dysfunction, but HIV infection is
The basics – making complex information simple
